clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Podcasts
Learning Labs
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Molecular Dx
RNA Molecular Signal of Severe Fetal Growth Restriction Found by Mirvie
News & Features
Trial Offers New Options for Drug-Resistant TB
Molecular Dx
New Study Identifies Blood Markers That May Predict Postpartum Depression Risk
News & Features
Engineered Heart Muscle Repairs Failing Rhesus Hearts, Goes First-in-Human
News & Features
Blood Test Identifies Advanced Colon Cancer Patients Who Benefit from Celecoxib
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Podcasts
Learning Labs
Inside Precision Medicine Live
Inside Precision Medicine
Takeda Signs Deal Worth $2.2 Billion with AC Immune for Alzheimer’s Vaccine
Takeda Pharmaceutical Company
News & Features
Takeda Signs Deal Worth $2.2 Billion with AC Immune for Alzheimer’s Vaccine
May 13, 2024
0
News & Features
SEQSTER Chosen to Drive Forward MS Care
March 21, 2024
0
News & Features
AcuraStem and Takeda Ink $580M Deal That Includes ALS Targets
September 26, 2023
0
News & Features
Astellas and PeptiDream Ink $21M Plus Protein Degrader Deal
July 25, 2023
0
News & Features
Takeda Spins Off Rare Disease Therapeutics Company Oak Hill Bio
February 1, 2022
0
News & Features
FDA, NIH and Private Partners Commit $76.5M to Launch the Bespoke Gene Therapy Consortium
October 28, 2021
0
News & Features
Takeda, Jounce Drug Candidate Mobilizes Immunity by Suppressing SUMOylation
September 24, 2021
0
Molecular Dx
Rady Children’s and Takeda Partner to Develop Treatments for Rare Genetic Diseases
Helen Albert
July 16, 2021
0
Informatics
Takeda Invests in Patient-Centric Health Data Company Seqster
Chris Anderson
February 13, 2020
0
eBooks
Better Understanding of Post-Translation Modifications Driving Innovation
January 27, 2020
0
1
2
Page 1 of 2
Related Content
From Bloodstream to Brain: Accessing the Neurogenetic Medicine Revolution
Study Links Anti-Inflammatories, Vaccines, and Antibiotics to Reduced Dementia Risk
Xenon Gas Inhalation Shows Promise for Alzheimer’s Disease
New Insights into T-Cell Role in Viral Defense Could Transform Vaccine Strategies
Inside Precision Medicine